John Wiley and Sons offers an attractive valuation at a forward price-to-earnings ratio near 9x with analyst upside over 50%, but heavy concentration in its research segment and an imminent earnings event create binary risk that warrants waiting before establishing a new position.
Thesis pillars
- Attractive Valuation Low Peg→Stable
- Earnings Beat Streak→Stable
- Research Segment Concentration Risk→Stable
- +1 more pillar — see the Why tab for full reasoning
John Wiley & Sons, Inc. (WLY) Stock Analysis
Communication Services · Publishing
Hold if already holding. Not a fresh buy at $52.17, but acceptable to hold if already in. Reasons: Concentration risk — Product: Research segment (64.0%); Concentration risk — Counterparty: Cengage Learning.
John Wiley & Sons publishes academic research journals, textbooks, courseware, and professional assessment products through two reportable segments, Research (64% of fiscal 2025 consolidated revenue) and Learning (35%), serving researchers, students, instructors, and... Read more
Hold if already holding. Not a fresh buy at $52.17, but acceptable to hold if already in. Reasons: Concentration risk — Product: Research segment (64.0%); Concentration risk — Counterparty: Cengage Learning. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 6.3/10, moderate confidence.
Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 60d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
About John Wiley & Sons, Inc.
About John Wiley & Sons, Inc.
Wiley publishes more than 1,800 peer-reviewed academic journals and generated 83% of its fiscal 2025 Adjusted Revenue from digital products, split between a Research segment (64% of consolidated revenue) and a Learning segment (35%) that together serve researchers, students, and corporations worldwide. Approximately 49% of consolidated revenue came from outside the United States in the year ended April 30, 2025.
Wiley earns Research segment revenue through Journal Subscriptions and Transformational Agreements (pay-to-read and pay-to-read-and-publish, sold via multi-year contracts to research libraries and consortia), Open Access publication fees, and licensing — including licensing content to AI model developers. Approximately 46% of Journal Subscriptions revenue comes from publication rights owned by professional societies and other partners such as the American Cancer Society and the American Heart Association, under decades-long alliance agreements that pay those societies a royalty. The Learning segment sells print and digital textbooks, courseware such as WileyPLUS and zyBooks, and assessments including Everything DiSC, distributed through bookstores, online retailers, and direct-to-student channels; Wiley owns no printing facilities and outsources its remaining US-based book distribution to Cengage Learning.
Show full overview
Wiley's operating footprint has grown thinner even as its content library has grown more valuable: the company reported just one remaining global warehousing and distribution facility, located in the UK, after agreeing to outsource its US-based book distribution to Cengage Learning. That consolidation cuts fixed costs but concentrates a physical function Wiley no longer controls directly with a single external partner, at the same time the 10-K flags generative AI developers' unauthorized copying of licensed content as a distinct and growing threat to the licensing revenue Wiley now also sells to those same AI model developers.
See also: Communication Services · Publishing
From John Wiley & Sons, Inc.'s most recent 10-K filing, extracted July 6, 2026.
Recent developments
updated 2026-07-07Recent Developments — John Wiley & Sons, Inc.
Latest news
- NEWS John Wiley & Sons Inc (WLY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey — TradingKey neutral
- NEWS Earnings Preview: WLY to Report Financial Results on June 16 - 富途牛牛 — 富途牛牛 neutral
- NEWS Earnings Preview: WLY to Report Financial Results on June 16 - Moomoo — Moomoo neutral
- NEWS Crude oil down 5%; John Wiley & Sons shares fall after Q4 results - MSN — MSN negative
- NEWS Is John Wiley & Sons Inc (WLY) Overvalued After 4.1% Rally? GF V - GuruFocus — GuruFocus neutral
Generated 2026-07-07T12:51:47Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHProductResearch segment64%10-K Item 1: 'Research revenue accounted for approximately 64% of our consolidated revenue in the year ended April 30, 2025'
- MEDIUMProductLearning segment35%10-K Item 1: 'Learning accounted for approximately 35% of our consolidated revenue in the year ended April 30, 2025'
- MEDIUMGeographicoutside the United States49%10-K Item 1: 'approximately 49% of our consolidated revenue was from outside the US'
- MEDIUMcounterpartyprofessional societies and publishing partners46%10-K Item 1: 'Approximately 46% of Journal Subscriptions revenue is derived from publication rights that are owned by professional societies and other publishing partners such as research institutions or foundations'
- HIGHcounterpartyCengage Learning10-K Item 1: 'We have an agreement to outsource our US-based book distribution operations to Cengage Learning'
Material Events(8-K, last 90d)
- 2026-05-06Item 5.02MEDIUMEVP and GM Research and Learning Jay Flynn departed without cause; Jessica Kowalski (previously Microsoft) named EVP and GM Research effective May 11, 2026. Flynn eligible for standard separation benefits under his employment letter.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker·1 ceiling hit
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $52.17, but acceptable to hold if already in. Reasons: Concentration risk — Product: Research segment (64.0%); Concentration risk — Counterparty: Cengage Learning. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Target $57.80 (+10.8%), stop $48.52 (−7.5%), A.R:R 0.7:1. Score 6.3/10, moderate confidence.
Take-profit target: $57.80 (+10.8% upside). Target $57.80 (+10.8%), stop $48.52 (−7.5%), A.R:R 0.7:1. Stop-loss: $48.52.
Concentration risk — Product: Research segment (64.0%); Concentration risk — Counterparty: Cengage Learning; Near 52-week high (1.5% away).
John Wiley & Sons, Inc. trades at a P/E of 12.7 (forward 10.0). TrendMatrix value score: 9.0/10. Verdict: Hold.
5 analysts cover WLY with a consensus score of 4.0/5. Average price target: $68.
What does John Wiley & Sons, Inc. do?John Wiley & Sons publishes academic research journals, textbooks, courseware, and professional assessment products...
John Wiley & Sons publishes academic research journals, textbooks, courseware, and professional assessment products through two reportable segments, Research (64% of fiscal 2025 consolidated revenue) and Learning (35%), serving researchers, students, instructors, and corporations primarily in the US and UK. The company generates 83% of its Adjusted Revenue from digital products, including over 1,800 peer-reviewed journals distributed via its Wiley Online Library and Atypon publishing platforms, with roughly 49% of revenue coming from outside the United States.